Open AccessA Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1
Author(s) -
Marc Lallemant,
Gonzague Jourdain,
Sophie Le Cœur,
Soyeon Kim,
Suporn Koetsawang,
Anne Marie Comeau,
Wiput Phoolcharoen,
Max Essex,
Kenneth McIntosh,
Vicharn Vithayasai
Publication year - 2000
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejm200010053431401
Subject(s) - regimen , zidovudine , medicine , confidence interval , interim analysis , interim , randomized controlled trial , pediatrics , immunology , human immunodeficiency virus (hiv) , viral disease , archaeology , history
The optimal duration of zidovudine administration to prevent perinatal transmission of human immunodeficiency virus type 1 (HIV-1) should be determined to facilitate its use in areas where resources are limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom